Predictors of mortality for nursing home-acquired pneumonia: a systematic review

Naveen Dhawan, Naushira Pandya, Michael Khalili, Manuel Bautista, Anurag Duggal, Jaya Bahl, Vineet Gupta, Naveen Dhawan, Naushira Pandya, Michael Khalili, Manuel Bautista, Anurag Duggal, Jaya Bahl, Vineet Gupta

Abstract

Background: Current risk stratification tools, primarily used for CAP, are suboptimal in predicting nursing home acquired pneumonia (NHAP) outcome and mortality. We conducted a systematic review to evaluate current evidence on the usefulness of proposed predictors of NHAP mortality.

Methods: PubMed (MEDLINE), EMBASE, and CINAHL databases were searched for articles published in English between January 1978 and January 2014. The literature search elicited a total of 666 references; 580 were excluded and 20 articles met the inclusion criteria for the final analysis.

Results: More studies supported the Pneumonia Severity Index (PSI) as a superior predictor of NHAP severity. Fewer studies suggested CURB-65 and SOAR (especially for the need of ICU care) as useful predictors for NHAP mortality. There is weak evidence for biomarkers like C-reactive protein and copeptin as prognostic tools.

Conclusion: The evidence supports the use of PSI as the best available indicator while CURB-65 may be an alternative prognostic indicator for NHAP mortality. Overall, due to the paucity of information, biomarkers may not be as effective in this role. Larger prospective studies are needed to establish the most effective predictor(s) or combination scheme to help clinicians in decision-making related to NHAP mortality.

Figures

Figure 1
Figure 1
Study flow of the selection process of all papers used in the final analysis.
Figure 2
Figure 2
The most frequent infective etiology of NHAP (estimates) [3].

References

    1. Furman C. D., Rayner A. V., Tobin E. P. Pneumonia in older residents of long-term care facilities. American Family Physician. 2004;70(8):1495–1500.
    1. El-Solh A. A., Niederman M. S., Drinka P. Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches. Current Medical Research and Opinion. 2010;26(12):2707–2714. doi: 10.1185/03007995.2010.530154.
    1. Mills K., Nelson A. C., Winslow B. T., Springer K. L. Treatment of nursing home-acquired pneumonia. American Family Physician. 2009;79(11):976–982.
    1. Sarin J., Balasubramaniam R., Corcoran A. M., Laudenbach J. M., Stoopler E. T. Reducing the risk of aspiration pneumonia among elderly patients in long-term care facilities through oral health interventions. Journal of the American Medical Directors Association. 2008;9(2):128–135. doi: 10.1016/j.jamda.2007.10.003.
    1. Marik P. E., Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124(1):328–336. doi: 10.1378/chest.124.1.328.
    1. Wójkowska-Mach J., Gryglewska B., Romaniszyn D., et al. Age and other risk factors of pneumonia among residents of Polish long-term care facilities. International Journal of Infectious Diseases. 2013;17(1):e37–e43. doi: 10.1016/j.ijid.2012.07.020.
    1. Richards C. Infections in residents of long-term care facilities: an agenda for research. Report of an expert panel. Journal of the American Geriatrics Society. 2002;50(3):570–576. doi: 10.1046/j.1532-5415.2002.50128.x.
    1. Mehr D. R., Zweig S. C., Kruse R. L., et al. Mortality from lower respiratory infection in nursing home residents: a pilot prospective community-based study. Journal of Family Practice. 1998;47(4):298–304.
    1. Norman D. C. Pneumonia in the elderly: empiric antimicrobial therapy. Geriatrics. 1991;46(12):26–32.
    1. Lee J.-C., Hwang H.-J., Park Y.-H., Joe J.-H., Chung J.-H., Kim S.-H. Comparison of severity predictive rules for hospitalised nursing home-acquired pneumonia in korea: a retrospective observational study. Primary Care Respiratory Journal. 2013;22(2):149–154. doi: 10.4104/pcrj.2013.00011.
    1. Mylotte J. M., Goodnough S., Gould M. Pneumonia versus aspiration pneumonitis in nursing home residents: prospective application of a clinical algorithm. Journal of the American Geriatrics Society. 2005;53(5):755–761. doi: 10.1111/j.1532-5415.2005.53258.x.
    1. Marrie T. J. Pneumonia in the long-term-care facility. Infection Control and Hospital Epidemiology. 2002;23(3):159–164. doi: 10.1086/502030.
    1. Muder R. R., Aghababian R. V., Loeb M. B., Solot J. A., Higbee M. Nursing home-acquired pneumonia: an emergency department treatment algorithm. Current Medical Research and Opinion. 2004;20(8):1309–1320. doi: 10.1185/030079904125004376.
    1. Ewig S., Klapdor B., Pletz M. W., et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax. 2012;67(2):132–138. doi: 10.1136/thoraxjnl-2011-200630.
    1. Loeb M. Pneumonia in older persons. Clinical Infectious Diseases. 2003;37(10):1335–1339. doi: 10.1086/379076.
    1. El Solh A. A., Akinnusi M. E., Alfarah Z., Patel A. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. Journal of the American Geriatrics Society. 2009;57(6):1030–1035. doi: 10.1111/j.1532-5415.2009.02279.x.
    1. Arinzon Z., Peisakh A., Schrire S., Berner Y. C-reactive protein (CRP): an important diagnostic and prognostic tool in nursing-home-associated pneumonia. Archives of Gerontology and Geriatrics. 2011;53(3):364–369. doi: 10.1016/j.archger.2011.01.006.
    1. Almirall J., Bolíbar I., Toran P., et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest. 2004;125(4):1335–1342. doi: 10.1378/chest.125.4.1335.
    1. Castell J. V., Gomez-Lechon M. J., David M., Fabra R., Trullenque R., Heinrich P. C. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology. 1990;12(5):1179–1186. doi: 10.1002/hep.1840120517.
    1. Porfyridis I., Georgiadis G., Vogazianos P., Mitis G., Georgiou A. Crp, pct, cpis and pneumonia severity scores in nursing home acquired pneumonia. Respiratory Care. 2014;59(4):574–581. doi: 10.4187/respcare.02741.
    1. Brito V., Niederman M. S. How can we improve the management and outcome of pneumonia in the elderly? European Respiratory Journal. 2008;32(1):12–14. doi: 10.1183/09031936.00039908.
    1. El-Solh A. A. Nursing home acquired pneumonia: approach to management. Current Opinion in Infectious Diseases. 2011;24(2):148–151. doi: 10.1097/qco.0b013e328343b6cc.
    1. Man S. Y., Graham C. A., Chan S. S. W., et al. Disease severity prediction for nursing home-acquired pneumonia in the emergency department. Emergency Medicine Journal. 2011;28(12):1046–1050. doi: 10.1136/emj.2010.107235.
    1. Moher D., Liberati A., Tetzlaff J., Altman D. G., PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of Internal Medicine. 2009;151(4):264–269, W64.
    1. Klapdor B., Ewig S., Schaberg T., et al. Presentation, etiology and outcome of pneumonia in younger nursing home residents. Journal of Infection. 2012;65(1):32–38. doi: 10.1016/j.jinf.2012.02.003.
    1. Marrie T. J., Durant H., Kwan C. Nursing home-acquired pneumonia. A case-control study. Journal of the American Geriatrics Society. 1986;34(10):697–702.
    1. Marrie T. J., Durant H., Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Reviews of Infectious Diseases. 1989;11(4):586–599. doi: 10.1093/clinids/11.4.586.
    1. Marrie T. J., Blanchard W. A comparison of nursing home-acquired pneumonia patients with patients with community-acquired pneumonia and nursing home patients without pneumonia. Journal of the American Geriatrics Society. 1997;45(1):50–55.
    1. Lim W. S., Macfarlane J. T. A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia. European Respiratory Journal. 2001;18(2):362–368. doi: 10.1183/09031936.01.00204401.
    1. Polverino E., Dambrava P., Cillóniz C., et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax. 2010;65(4):354–359. doi: 10.1136/thx.2009.124776.
    1. Garcia-Vidal C., Viasus D., Roset A., et al. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clinical Microbiology and Infection. 2011;17(11):1659–1665. doi: 10.1111/j.1469-0691.2011.03484.x.
    1. Loed M. Epidemiology of community- and nursing home-acquired pneumonia in older adults. Expert Review of Anti-Infective Therapy. 2005;3(2):263–270. doi: 10.1586/14787210.3.2.263.
    1. Hutt E., Ruscin J. M., Corbett K., et al. A multifaceted intervention to implement guidelines improved treatment of nursing home-acquired pneumonia in a state veterans home. Journal of the American Geriatrics Society. 2006;54(11):1694–1700. doi: 10.1111/j.1532-5415.2006.00937.x.
    1. Mandell L. A., Wunderink R. G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults. Clinical Infectious Diseases. 2007;44(supplement 2):S27–S72. doi: 10.1086/511159.
    1. Ma H. M., Lee Shun Wah J., Woo J. Should nursing home-acquired pneumonia be treated as nosocomial pneumonia? Journal of the American Medical Directors Association. 2012;13(8):727–731. doi: 10.1016/j.jamda.2012.07.006.
    1. El-Solh A. A., Sikka P., Ramadan F., Davies J. Etiology of severe pneumonia in the very elderly. The American Journal of Respiratory and Critical Care Medicine. 2001;163(3, part 1):645–651. doi: 10.1164/ajrccm.163.3.2005075.
    1. Ewig S., Welte T., Chastre J., Torres A. Rethinking the concepts of community-acquired and health-care-associated pneumonia. The Lancet Infectious Diseases. 2010;10(4):279–287. doi: 10.1016/S1473-3099(10)70032-3.
    1. Liapikou A., Polverino E., Cilloniz C., et al. A worldwide perspective of nursing home-acquired pneumonia compared with community-acquired pneumonia. Respiratory Care. 2014;59(7):1078–1085. doi: 10.4187/respcare.02788.
    1. Rashid H., Shafi S., Booy R., et al. Influenza and respiratory syncytial virus infections in British Hajj pilgrims. Emerging Health Threats Journal. 2008;1:p. e2. doi: 10.3134/ehtj.08.002.
    1. Falsey A. R., Walsh E. E. Respiratory syncytial virus infection in elderly adults. Drugs and Aging. 2005;22(7):577–587. doi: 10.2165/00002512-200522070-00004.
    1. Mandell L. A., Bartlett J. G., Dowell S. F., File T. M., Jr., Musher D. M., Whitney C. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clinical Infectious Diseases. 2003;37(11):1405–1433. doi: 10.1086/380488.
    1. Mandell L. A., Marrie T. J., Grossman R. F., Chow A. W., Hyland R. H. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical Infectious Diseases. 2000;31(2):383–421.
    1. Lim W. S., Baudouin S. V., George R. C., et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(supplement 3):iii1–iii55.
    1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine. 2005;171(4):388–416. doi: 10.1164/rccm.200405-644st.
    1. El-Solh A. A., Pietrantoni C., Bhat A., et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. American Journal of Respiratory and Critical Care Medicine. 2003;167(12):1650–1654. doi: 10.1164/rccm.200212-1543oc.
    1. van der Steen J. T., Ooms M. E., Mehr D. R., van der Wal G., Ribbe M. W. Severe dementia and adverse outcomes of nursing home-acquired pneumonia: evidence for mediation by functional and pathophysiological decline. Journal of the American Geriatrics Society. 2002;50(3):439–448. doi: 10.1046/j.1532-5415.2002.50108.x.
    1. Fine M. J., Auble T. E., Yealy D. M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. The New England Journal of Medicine. 1997;336(4):243–250.
    1. Lim W. S., van der Eerden M. M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377–382. doi: 10.1136/thorax.58.5.377.
    1. Ebell M. H. Outpatient vs. inpatient treatment of community-acquired pneumonia. Family Practice Management. 2006;13(4):41–44.
    1. El-Solh A. A., Alhajhusain A., Abou Jaoude P., Drinka P. Validity of severity scores in hospitalized patients with nursing home-acquired pneumonia. Chest. 2010;138(6):1371–1376. doi: 10.1378/chest.10-0494.
    1. Ma H. M., Lee K. P., Woo J. Predictors of viral pneumonia: the need for viral testing in all patients hospitalized for nursing home-acquired pneumonia. Geriatrics and Gerontology International. 2013;13(4):949–957. doi: 10.1111/ggi.12036.
    1. Menéndez R., Martínez R., Reyes S., et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax. 2009;64(7):587–591. doi: 10.1136/thx.2008.105312.
    1. Niederman M. S. Recent advances in community-acquired pneumonia: inpatient and outpatient. Chest. 2007;131(4):1205–1215. doi: 10.1378/chest.06-1994.
    1. Naughton B. J., Mylotte J. M., Tayara A. Outcome of nursing home-acquired pneumonia: derivation and application of a practical model to predict 30 day mortality. Journal of the American Geriatrics Society. 2000;48(10):1292–1299.
    1. British Thoracic Society, Myint P. K., Kamath A. V., Vowler S. L., Maisey D. N., Harrison B. D. Severity assessment criteria recommended by the British Thoracic Society (BTS) for community-acquired pneumonia (CAP) and older patients. Should SOAR (systolic blood pressure, oxygenation, age and respiratory rate) criteria be used in older people? A compilation study of two prospective cohorts. Age Ageing. 2006;35(3):286–291.
    1. Charles P. G. P., Wolfe R., Whitby M., et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clinical Infectious Diseases. 2008;47(3):375–384. doi: 10.1086/589754.
    1. España P. P., Capelastegui A., Gorordo I., et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. The American Journal of Respiratory and Critical Care Medicine. 2006;174(11):1249–1256. doi: 10.1164/rccm.200602-177oc.
    1. Ewig S., Ruiz M., Mensa J., et al. Severe community-acquired pneumonia: assessment of severity criteria. American Journal of Respiratory and Critical Care Medicine. 1998;158(4):1102–1108. doi: 10.1164/ajrccm.158.4.9803114.
    1. Niederman M. S., Mandell L. A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia diagnosis, assessment of severity, antimicrobial therapy, and prevention. The American Journal of Respiratory and Critical Care Medicine. 2001;163(7):1730–1754. doi: 10.1164/ajrccm.163.7.at1010.
    1. Porfyridis I., Plachouras D., Karagianni V., et al. Diagnostic value of triggering receptor expressed on myeloid cells-1 and C-reactive protein for patients with lung infiltrates: an observational study. BMC Infectious Diseases. 2010;10, article 286 doi: 10.1186/1471-2334-10-286.
    1. Fartoukh M., Maître B., Honoré S., Cerf C., Zahar J.-R., Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. American Journal of Respiratory and Critical Care Medicine. 2003;168(2):173–179. doi: 10.1164/rccm.200212-1449oc.
    1. Torres O. H., Muñoz J., Ruiz D., et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. Journal of the American Geriatrics Society. 2004;52(10):1603–1609. doi: 10.1111/j.1532-5415.2004.52492.x.
    1. Ugajin M., Yamaki K., Hhirasawa N., Kobayashi T., Yagi T. Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients. Clinical Interventions in Aging. 2014;9:267–274. doi: 10.2147/CIA.S58682.
    1. Deng J. C., Standiford T. J. The systemic response to lung infection. Clinics in Chest Medicine. 2005;26(1):1–9. doi: 10.1016/j.ccm.2004.10.009.
    1. Nelson S. Novel nonantibiotic therapies for pneumonia: cytokines and host defense. Chest. 2001;119(2, supplement):419S–425S.
    1. Skerrett S. J., Park D. R. Anti-inflammatory treatment of acute and chronic pneumonia. Seminars in Respiratory Infections. 2001;16(1):76–84. doi: 10.1053/srin.2001.22731.
    1. Kim S.-H., Chung J.-H., Lee J.-C., Park Y.-H., Joe J.-H., Hwang H.-J. Carboxy-terminal provasopressin may predict prognosis in nursing home acquired pneumonia. Clinica Chimica Acta. 2013;421:226–229. doi: 10.1016/j.cca.2013.02.022.
    1. Smith R. P., Lipworth B. J., Cree I. A., Spiers E. M., Winter J. H. C-reactive protein: a clinical marker in community-acquired pneumonia. Chest. 1995;108(5):1288–1291. doi: 10.1378/chest.108.5.1288.
    1. García Vázquez E., Martínez J. A., Mensa J., et al. C-reactive protein levels in community-acquired pneumonia. European Respiratory Journal. 2003;21(4):702–705. doi: 10.1183/09031936.03.00080203.
    1. Macfarlane J. T., Boldy D. 2004 update of BTS pneumonia guidelines: what's new? Thorax. 2004;59(5):364–366. doi: 10.1136/thx.2004.024992.
    1. Katan M., Christ-Crain M. The stress hormone copeptin: a new prognostic biomarker in acute illness. Swiss Medical Weekly. 2010;140w13101
    1. Nickel C. H., Bingisser R., Morgenthaler N. G. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Medicine. 2012;10, article 7 doi: 10.1186/1741-7015-10-7.
    1. Katan M., Müller B., Christ-Crain M. Copeptin: a new and promising diagnostic and prognostic marker. Critical Care. 2008;12(2, article 117) doi: 10.1186/cc6799.
    1. Morgenthaler N. G., Struck J., Alonso C., Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical Chemistry. 2006;52(1):112–119. doi: 10.1373/clinchem.2005.060038.
    1. Jochberger S., Morgenthaler N. G., Mayr V. D., et al. Copeptin and arginine vasopressin concentrations in critically Ill patients. Journal of Clinical Endocrinology and Metabolism. 2006;91(11):4381–4386. doi: 10.1210/jc.2005-2830.
    1. Chen L.-K., Peng L.-N., Lin M.-H., Lai H.-Y., Lin H.-C., Hwang S.-J. Diabetes mellitus, glycemic control, and pneumonia in long-term care facilities: a 2-year, prospective cohort study. Journal of the American Medical Directors Association. 2011;12(1):33–37. doi: 10.1016/j.jamda.2010.01.010.
    1. Chosa T. Analysis of common infectious diseases in elderly health service facility. International Journal of Infectious Diseases. 2012;16, supplement 1:e369–e370. doi: 10.1016/j.ijid.2012.05.470.
    1. Gryglewska B., Wojkowska-Mach J., Grodzicki T., Heczko P. Risk of nursing home acquired pneumonia and clinical characteristics of residents. European Geriatric Medicine. 2013;4:p. S118. doi: 10.1016/j.eurger.2013.07.387.
    1. Gussoni G., Iori I., Blasi F., et al. Pneumonia in nursing home patients: is it time for a specific therapeutic strategy? Italian Journal of Medicine. 2009;3(4):212–219. doi: 10.1016/j.itjm.2009.09.004.
    1. Hutt E., Frederickson E. B., Ecord M., Kramer A. M. Processes of care predict survival following nursing home-acquired pneumonia. Journal of Clinical Outcomes Management. 2002;9(5):249–256.
    1. Hutt E., Ruscin J. M., Linnebur S. A., et al. A multifaceted intervention to implement guidelines did not affect hospitalization rates for nursing home-acquired pneumonia. Journal of the American Medical Directors Association. 2011;12(7):499–507. doi: 10.1016/j.jamda.2010.03.011.
    1. van der Steen J. T., Ooms M. E., Mehr D. R., Van der Wal G., Ribbe M. W. Severe dementia and adverse outcomes of nursing home-acquired pneumonia: evidence for mediation by functional and pathophysiological decline. Journal of the American Geriatrics Society. 2002;50(3):439–448. doi: 10.1046/j.1532-5415.2002.50108.x.
    1. Ma H. M., Ip M., Hui E., Chan P. K. S., Hui D. S. C., Woo J. Role of atypical pathogens in nursing home-acquired pneumonia. Journal of the American Medical Directors Association. 2013;14(2):109–113. doi: 10.1016/j.jamda.2012.10.002.
    1. Ma H. M., Wah J. L. S., Woo J. Should nursing home-acquired pneumonia be treated as nosocomial pneumonia? Journal of the American Medical Directors Association. 2012;13(8):727–731. doi: 10.1016/j.jamda.2012.07.006.
    1. Man S. Y., Graham C. A., Chan S. S. W., et al. Disease severity prediction for nursing home-acquired pneumonia in the emergency department. Emergency Medicine Journal. 2011;28(12):1046–1050. doi: 10.1136/emj.2010.107235.
    1. Mylotte J. M., Naughton B., Saludades C., Maszarovics Z. Validation and application of the pneumonia prognosis index to nursing home residents with pneumonia. Journal of the American Geriatrics Society. 1998;46(12):1538–1544.
    1. Sund-Levander M., Örtqvist Å., Grodzinsky E., Klefsgård Ö., Wahren L. K. Morbidity, mortality and clinical presentation of nursing home-acquired pneumonia in a Swedish population. Scandinavian Journal of Infectious Diseases. 2003;35(5):306–310. doi: 10.1080/00365540310008456.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit